Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Bengt Hallberg

Professor

Bengt Hallberg
Professor , Avd-/sektionschef, inst
bengt.hallberg@gu.se
+46 31 786 3815
0705-665742

Postal Address: Box 440, 40530 Göteborg
Visiting Address: Medicinaregatan 9 a-b , 41390 Göteborg


Department of Medical Biochemistry and Cell biology at Institute of Biomedicine (More Information)
Box 440
405 30 Göteborg
Fax: +46 31416108
Visiting Address: Medicinaregatan 9 A-B , 413 90 Göteborg

Latest publications

Molecular targeting of various human tumor cell lines with 177Lu-octreotate
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Annual Congress of the European Association of Nuclear Medicine , Conference contribution 2018
Conference contribution

In vitro screening for Lu-177-octreotate uptake in human tumor cell lines
Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg et al.
Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi höstmöte 2017, Conference contribution 2017
Conference contribution

Therapeutic potential of Lu-177-octreotate for neuroblastoma – preclinical studies
Arman Romiani, Johan Spetz, Emil Schüler, Haiying Wang, Ruth H. Palmer et al.
NOPHO 35th Annual meeting 2017 19 - 23 May, Stockholm, Sweden , Conference contribution 2017
Conference contribution

Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation.
Jikui Guan, Yasuo Yamazaki, Damini Chand, Jesper R van Dijk, Kristina Ruuth et al.
Cancers, Journal article 2017
Journal article

Dose-response study of Lu-177-octreotate in nude mice bearing human neuroblastoma
Arman Romiani, Johan Spetz, Ruth H. Palmer, Bengt Hallberg, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Binding and internalization of 177Lu-octreotate in human tumor cell lines of different origin
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Jikui Guan, E. R. Tucker, Haiying Wang, Damini Chand, L. S. Danielson et al.
DMM Disease Models and Mechanisms, Journal article 2016
Journal article

Showing 1 - 10 of 31

2018

Molecular targeting of various human tumor cell lines with 177Lu-octreotate
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
Annual Congress of the European Association of Nuclear Medicine , Conference contribution 2018
Conference contribution

2017

In vitro screening for Lu-177-octreotate uptake in human tumor cell lines
Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg et al.
Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi höstmöte 2017, Conference contribution 2017
Conference contribution

Therapeutic potential of Lu-177-octreotate for neuroblastoma – preclinical studies
Arman Romiani, Johan Spetz, Emil Schüler, Haiying Wang, Ruth H. Palmer et al.
NOPHO 35th Annual meeting 2017 19 - 23 May, Stockholm, Sweden , Conference contribution 2017
Conference contribution

Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation.
Jikui Guan, Yasuo Yamazaki, Damini Chand, Jesper R van Dijk, Kristina Ruuth et al.
Cancers, Journal article 2017
Journal article

Dose-response study of Lu-177-octreotate in nude mice bearing human neuroblastoma
Arman Romiani, Johan Spetz, Ruth H. Palmer, Bengt Hallberg, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Binding and internalization of 177Lu-octreotate in human tumor cell lines of different origin
Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer et al.
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

2016

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Jikui Guan, E. R. Tucker, Haiying Wang, Damini Chand, L. S. Danielson et al.
DMM Disease Models and Mechanisms, Journal article 2016
Journal article

Showing 1 - 10 of 31

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?